| Date Filed | Type | Description |
| 10/02/2023 |
4
| VAN NOSTRAND ROBERT L (Director) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Granted 105 shares
@ $52.09, valued at
$5.5k
|
|
| 10/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2023 |
4
| VAN NOSTRAND ROBERT L (Director) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Granted 85 shares
@ $63.32, valued at
$5.4k
|
|
| 07/05/2023 |
4
| VAN NOSTRAND ROBERT L (Director) has filed a Form 4 on YIELD10 BIOSCIENCE, INC.|
Txns:
| Granted 2,040 shares
@ $0 |
|
| 05/30/2023 |
4
| VAN NOSTRAND ROBERT L (Director) has filed a Form 4 on YIELD10 BIOSCIENCE, INC.|
Txns:
| Granted 5,000 options to buy
@ $2.81, valued at
$14.1k
|
|
| 04/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/04/2023 |
4
| VAN NOSTRAND ROBERT L (Director) has filed a Form 4 on YIELD10 BIOSCIENCE, INC.|
Txns:
| Granted 1,642 shares
@ $0 |
|
| 04/04/2023 |
4
| VAN NOSTRAND ROBERT L (Director) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Granted 95 shares
@ $54.15, valued at
$5.1k
|
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/05/2022 |
4
| VAN NOSTRAND ROBERT L (Director) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Granted 110 shares
@ $46.53, valued at
$5.1k
|
|
| 10/03/2022 |
4
| VAN NOSTRAND ROBERT L (Director) has filed a Form 4 on YIELD10 BIOSCIENCE, INC.|
Txns:
| Granted 1,601 options to buy
@ $2.99, valued at
$4.8k
|
|
| 08/12/2022 |
4
| VAN NOSTRAND ROBERT L (Director) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Sold 28,500 shares
@ $57.15, valued at
$1.6M
Sold 1,500 shares
@ $56.8, valued at
$85.2k
Exercised 20,000 options to buy
@ $12.45, valued at
$249k
Exercised 10,000 options to buy
@ $13.05, valued at
$130.5k
|
|
| 07/05/2022 |
4
| VAN NOSTRAND ROBERT L (Director) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Granted 108 shares
@ $57.08, valued at
$6.2k
|
|
| 07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| VAN NOSTRAND ROBERT L (Director) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Granted 16,757 options to buy
@ $55.48, valued at
$929.7k
|
|
| 05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/04/2022 |
4
| VAN NOSTRAND ROBERT L (Director) has filed a Form 4 on YIELD10 BIOSCIENCE, INC.|
Txns:
| Granted 908 options to buy
@ $5.3, valued at
$4.8k
|
|
| 04/04/2022 |
4
| VAN NOSTRAND ROBERT L (Director) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Granted 126 shares
@ $61.19, valued at
$7.7k
|
|
| 02/01/2022 |
4
| VAN NOSTRAND ROBERT L (Director) has filed a Form 4 on SELLAS Life Sciences Group, Inc.|
Txns:
| Granted 1,900 shares
@ $0
Granted 7,125 options to buy
@ $5.34, valued at
$38k
|
|
| 01/04/2022 |
4
| VAN NOSTRAND ROBERT L (Director) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Granted 148 shares
@ $52.34, valued at
$7.7k
|
|
| 01/03/2022 |
4
| VAN NOSTRAND ROBERT L (Director) has filed a Form 4 on YIELD10 BIOSCIENCE, INC.|
Txns:
| Granted 976 options to buy
@ $4.92, valued at
$4.8k
|
|
| 10/04/2021 |
4
| VAN NOSTRAND ROBERT L (Director) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Granted 215 shares
@ $37.28, valued at
$8k
|
|
| 10/04/2021 |
4
| VAN NOSTRAND ROBERT L (Director) has filed a Form 4 on YIELD10 BIOSCIENCE, INC.|
Txns:
| Granted 801 options to buy
@ $5.99, valued at
$4.8k
|
|
| 07/02/2021 |
4
| VAN NOSTRAND ROBERT L (Director) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Granted 173 shares
@ $40.82, valued at
$7.1k
|
|
| 07/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2021 |
4
| VAN NOSTRAND ROBERT L (Director) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Granted 20,000 options to buy
@ $43.45, valued at
$869k
|
|
| 05/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|